USA TODAY markets reporter Matt Krantz answers a different reader question every weekday. To submit a question, e-mail Matt at mkrantz@usatoday.com.
Q: What does it mean that IPOs are popping again?
A: During the dot-com boom, if your IPO didn't go up 50% or more, investors thought there was something wrong.
During 1999, the peak year of the dot-com boom, 117 initial public offerings doubled on their first day of trading, says Jay Ritter, professor of finance at the University of Florida. That's three times the 39 IPOs that doubled on their first day of trading during the previous 24 years combined, Ritter says.
MARKETS: IPO demand jumps as flurry of deals hits the market
Seeing stocks soar on their first day remains extremely rare, but it's making a bit of a comeback. Shares of restaurant chain Potbelly more than doubled on their first day on Oct. 4.
Haemonetics Corporation, incorporated on August 29, 1985, is a healthcare company engaged in providing blood management solutions to its customers. The Company�� portfolio of integrated devices, information management and consulting services offers blood management solutions for each facet of the blood supply chain, helping improve clinical outcomes and reduce costs for blood and plasma collectors, hospitals, and patients around the world.The Company serves three markets: manufacturers of plasma derived pharmaceuticals, blood collectors and hospitals. Plasma includes plasma collection devices and consumables. Blood Center includes blood collection and processing devices and consumables. Hospital includes surgical blood salvage and blood demand diagnostic devices and consumables. Software Solutions includes information technology platforms and consulting services provided to all three markets. On April 30, 2013, the Company acquired of certain assets of Hemerus LLC.
The Company helps its customers create and maintain a safe and efficient blood supply chain. Specifically, it develops and markets a wide range of systems used with plasma and blood donors that collect and process blood into its components using both manual and automated methods. It also develops and markets a variety of systems to hospitals that automate the cleaning and reinfusion of a surgical patient's blood during surgery, automate the tracking and distribution of blood in the hospital, and enhance blood diagnostics. The Company sells information technology platforms to promote efficient and compliant operations for all of its customer groups. The Company provides consulting services to reduce costs and improve operating efficiencies in blood management. . Its products and services help prevent a transfusion to a patient who does not need one and provide the right blood product, at the right time, in the right dose to the patient who does.
Plasma
Human plasma is collected and processed by bio-ph! armaceutical companies into therapeutic and diagnostic products that aid in the treatment of immune diseases and coagulation disorders. While plasma is also used to aid patients with extreme blood loss, such as trauma victims, this portion of its business solely focuses on plasma's pharmaceutical uses. Automated plasma collection technology allows for the safe and efficient collection of plasma. The Company manufactures and market plasma collection devices and respective disposables, but do not make plasma-derived pharmaceuticals.
The Company�� portfolio of products and services is designed to support multiple facets of plasma collector operations. The Company with its PCS brand automated plasma collection technology, more plasma can be collected during any one donation event because the other blood components are returned to the donor through the sterile disposable sets used for the plasma donation procedure. The Company offers one stop shopping to its plasma collection customers, enabling them to source from them the full range of products necessary for plasma collection and storage, including PCS brand plasma collection equipment and consumables, plasma collection containers, and intravenous solutions. It also offers a robust portfolio of integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain. Its products automate the donor interview and qualification process; streamline the workflow process in the plasma center; provide the controls necessary to evaluate donor suitability; determine the ability to release units collected; and manage unit distribution.
Blood Center
The Company offers automated blood component and manual whole blood collection systems to blood collection centers to collect blood products.The Company markets the MCS (Multicomponent Collection System) brand apheresis equipment which is designed to collect specific blood components integrated from the donor. Utilizing t! he MCS au! tomated platelet collection protocols, blood centers collect one or more therapeutic doses of platelets during a single donation by a volunteer blood donor. The MCS two-unit protocol or double red cell collection device helps blood collectors optimize the collection of red cells by automating the blood separation function, eliminating the need for laboratory processing, and enabling the collection of two units of red cells from a single donor thus maximizing the amount of red cells collected per eligible donor and helping to mitigate red cell shortages in countries where this problem exists. Blood collectors can also use the MCS system to collect one unit of red cells and a jumbo (double) unit of plasma, or one unit of red cells and one unit of platelets from a single donor. The MCS plasma protocol providing the possibility to collect 600-800ml of plasma for transfusion to patients or for pharmaceutical industry use completes the comprehensive portfolio of different blood component collection options on this device.
The Company offers a portfolio of products for manual whole blood collection and processing. Haemonetics' portfolio of disposable whole blood collection and component storage sets offer flexibility in collecting a unit of whole blood and the subsequent production and storage of the red blood cell, platelet, and/or plasma products, including options for in-line or dockable filters for leukoreduction of any blood component. In addition Acrodose product line provides a closed system for the pooling, storage, and bacteria testing of leukoreduced whole blood derived platelet concentrates, an Acrodose Platelet, that is transfusion ready for the hospital. Use of Acrodose platelets lowers hospital handling costs by eliminating the need for pooling and bacteria testing at the hospital.
The Company with ACP(Automated Cell Processor) brand offers a small bench-top solution to automate the washing and freezing of red cell components in the lab. The automated red cell was! hing proc! edure removes plasma proteins within the red cell units to provide a safer product for transfusion to frequently transfused patients, neonates, or patients with a history of transfusion reactions. The automated glycerolization and deglycerolization steps are required to prepare red cells for frozen storage. Freezing the red cell units can expand the shelf life of these products up to 10 years. Customers utilize this technology to implement strategic red cell inventories for catastrophe cases, storage of rare blood types, or enhanced inventory management.
Hospital
The Company offers a range of blood management solutions that significantly improve a hospital's systems for acquiring blood, storing it in the hospital, and dispensing it efficiently and correctly. Its products and integrated solution platforms help hospitals optimize performance of blood acquisition, storage, and distribution.The Company�� TEG Thrombelastograph Hemostasis Analyzer system is a blood diagnostic instrument that measures a patient's hemostasis or the ability to form and maintain blood clots.
The Cell Saver system is a surgical blood salvage system targeted to procedures that involve rapid, high-volume blood loss, such as cardiovascular surgeries. It has become the standard of care for high blood-loss surgeries. During the year ended December 31,2012, the Company launched the Cell Saver Elite system, which is autotransfusion option to minimize allogeneic blood use for surgeries with medium to high blood loss. The OrthoPAT surgical blood salvage system is targeted to procedures, such as orthopedic, that involve slower, lower volume blood loss that often occurs well after surgery. The cardioPAT system is a surgical blood salvage system targeted to open heart surgeries when there is less blood loss during surgery, but where the blood loss continues post-surgery. These systems are designed to remain with the patient following surgery, to recover blood and produce a washed red cell produ! ct for au! totransfusion. Their Quick-Connect feature permits customers to utilize the blood processing set selectively, depending on the patient's need.
The Company�� IMPACT Online Web-based software platform, which monitors and measures improvements in a hospital�� blood management practices, provides hospitals with a baseline view of their blood management metrics and helps monitor transfusion rates. Business consulting solutions are offered to support process and blood management efforts. It also provides blood management assessment tools to hospitals that enables its customers to monitor their progress in order to continually improve their blood management performance.
Software Solutions
The Companby has a suite of integrated software solutions for improving efficiencies and helping ensure donor and patient safety. This includes solutions for blood drive planning, donor recruitment and retention, blood collection, component manufacturing and distribution, transfusion management, and remote blood allocation. For its plasma customers, it also provides information technology platforms for managing donors and information associated with the collection of plasma products within fractionation facilities.
The Company�� software solutions , including information technology platforms and consulting services can be combined with its devices and sold through its plasma, blood center, and hospital sales forces. The Company�� software products help hospitals track and safely deliver stored blood products. SafeTrace Tx is its software solution that helps manage blood product inventory, perform patient cross-matching, and manage transfusions. In addition, its BloodTrack suite of solutions manages tracking and control of blood products from the hospital blood center through to transfusion to the patient. Smart refrigerators located in or near operating suites, emergency rooms, and other parts of the hospital dispense blood units with secure control and autom! ated trac! eability for efficient documentation. With its offerings, hospitals are better able to manage processes across the blood supply chain and identify increased opportunities to reduce costs and enhance processes. Its software solutions, such as its SafeTrace and El Dorado Donor donation and blood unit management systems, span blood center operations and automate and track operations from the recruitment of the blood donor to the disposition of the blood product. Its Hemasphere software solution provides support for more efficient blood drive planning, and Donor Doc and e-Donor software help to improve recruitment and retention.
The Company competes with Fenwal, Inc., Terumo BCT ,Caridian BCT, Rotem, MAK Systems, Mediware, MacoPharma , Medtronic, Fresenius, Sunquest Information Systems and Sorin Biomedica.
Advisors' Opinion: - [By Jake L'Ecuyer]
Haemonetics (NYSE: HAE) tumbled 1.13 percent to $42.06 after analysts at Benchmark downgraded the stock from Buy to Hold and lowered the target price from $49 to $46.
- [By Monica Gerson]
Analysts at Benchmark downgraded Haemonetics (NYSE: HAE) from ��uy��to ��old.��The target price for Haemonetics has been lowered from $49 to $46.
Hot Forestry Stocks To Own For 2014: Zygo Corporation(ZIGO)
Zygo Corporation designs, develops, and manufactures ultra-high precision measurement solutions to enhance its customers? manufacturing yields, and optical sub-systems and components for original equipment manufacturer and end-user applications in the Americas, the Far East, and Europe. It operates in two segments, Metrology Solutions and Optical Systems. The Metrology Solutions segment offers 3-Dimensional surface metrology products, precision positioning systems, and custom engineered solutions that are used to measure surface characteristics and critical parameters, including topography and roughness, shape, dimension, thickness, optical characteristics, and defects. This segment primarily provides NewView Series 3D Optical Profilers for fuel injector components; ZeGage to measure and visualize various materials, including rubber, paper, metal, plastic, and ceramics; VeriFire Asphere system that provides high resolution 3-Dimensional surface metrology for aspheric shap ed surfaces; VeriFire Systems, which are optical systems; GPI and VeriFire systems for the defense/aerospace market; and semiconductor products. It serves automotive, consumer electronics, medical, aerospace, military, materials research, optics, flat panel displays, and semiconductor industries. The Optical Systems segment manufactures high precision optical components and electro-optical systems used in the semiconductor, defense, life-sciences, and research markets. It offers defense-related products comprising lenses, windows, freeform optics and assemblies, and meter class optical components; life-science products, such as laser eye correction, dental 3D imaging, and genomic analysis instruments; and custom components and assemblies used in the manufacture of semiconductor chips. The company markets its products through direct sales force, as well as through independent agents and distributors. Zygo Corporation was founded in 1970 and is headquartered in Middlefield, Co nnecticut.
Advisors' Opinion: Hot Forestry Stocks To Own For 2014: Acxiom Corporation(ACXM)
Acxiom Corporation provides marketing technology and services that enable marketers to manage audience, personalize consumer experiences, and create customer relationships. It operates in two segments, Information Services and Information Products. The Information Services segment offers customer data integration, multichannel marketing services, infrastructure management services, and consulting services. This segment also develops, sells, and delivers industry-tailored solutions, including the design and creation of marketing databases and data warehouses; data integration and customer-recognition systems; marketing applications; list processing; and information technology services. The Information Products segment develops and sells various data products, including segmentation products and domestic fraud and risk mitigation products, as well as online advertising products. This segment provides InfoBase-Xa, a customer-centric foundation for various marketing needs with a collection of the United States consumer information available in one source; PersonicXa, a household segmentation and visualization system; and Acxiom Relevance-Xa, an online advertising network that lets marketers reach the consumers interested in their particular product or service. The company serves clients in financial services, insurance, information services, direct marketing, media, retail, consumer packaged goods, technology, automotive, healthcare, travel, and telecommunications industries. It offers its products and services in the United States, Europe, the Asia Pacific, and the Middle East. The company was founded in 1969 and is headquartered in Little Rock, Arkansas.
Advisors' Opinion: - [By Tom Taulli]
A key to Facebook�� monetization success has been the company�� aggressive investments in ad technologies. For example, by leveraging third-party data sources — such as from Datalogix, Acxiom (ACXM) and Alliance Data Systems (ADS) — it has been able to provide analytics on the performance of ad campaigns. On the Q4 earnings call, Facebook COO Sheryl Sandberg said the average return on News Feed ads was an incredible 8x.
- [By Sally Jones]
Acxiom Corporation (ACXM): Reduced
Up 47% over 12 months, Acxiom Corporation has a market cap of $1.84 billion; its shares were traded at around $24.98 with a P/E ratio of 33.40 and a P/B of 3.00.
Hot Forestry Stocks To Own For 2014: Fiat Chrysler Automobiles NV (FCAU)
Fiat Chrysler Automobiles NV is an international automotive company. The Company is engaged in designing, engineering, manufacturing, distributing and selling vehicles and components and production systems. The Company operates in approximately 40 countries and its products are sold directly or through distributors and dealers in more than 150 countries. It designs, engineers, manufactures, distributes and sells vehicles for the mass market under the Abarth, Alfa Romeo, Chrysler, Dodge, Fiat, Fiat Professional, Jeep, Lancia and Ram brands and the SRT performance vehicle designation. It operates in six segments: four regional mass-market vehicle segments, which include United States, Canada and Mexico (NAFTA), South and Central America, excluding Mexico (LATAM), Asia and Pacific countries (APAC) and Europe, Middle East and Africa (EMEA), a global Luxury Brands segment, and a global Components segment.
The Company support its vehicle sales with after-sales services and products worldwide under the Mopar brand and, in certain markets, with retail and dealer financing, leasing and rental services, which it makes available through its subsidiaries, joint ventures and commercial arrangements. The Company designs, engineers, manufactures, distribute and sell luxury vehicles under the Ferrari and Maserati brands, which it support with financial services provided to dealers and retail customers. It also operates in the components and production systems sectors through the Magneti Marelli, Teksid and Comau brands.
The Company�� four regional mass-market vehicle reportable segments deal with the design, engineering, development, manufacturing, distribution and sale of passenger cars, light commercial vehicles and related parts and services in specific geographic areas: NAFTA, LATAM, APAC and EMEA. It also operates on a global basis in the luxury vehicle and components sectors. In the luxury vehicle sector, it has the operating segments Ferrari and Maserati, while in the components se! ctor the Company has the operating segments Magneti Marelli, Teksid and Comau. The Company supports its mass-market vehicle sales with the sale of related service parts and accessories, as well as service contracts under the Mopar brand name.
The Company�� NAFTA operations supports distribution and sales of mass-market vehicles in the United States, Canada and Mexico, primarily through the Chrysler, Dodge, Fiat, Jeep and Ram brands. Its LATAM operations support the distribution and sale of mass-market vehicles in South and Central America (excluding Mexico), primarily under the Chrysler, Dodge, Fiat, Jeep and Ram brands, with the focus of its business in the LATAM segment in Brazil and Argentina. Its APAC operations supports the distribution and sale of mass-market vehicles in the Asia Pacific region (mostly in China, Japan, Australia, South Korea and India), primarily under the Abarth, Alfa Romeo, Chrysler, Dodge, Fiat and Jeep brands. Its EMEA operations support the distribution and sale of mass-market vehicles in Europe, the Middle East and Africa, primarily under the Abarth, Alfa Romeo, Chrysler, Fiat, Fiat Professional, Jeep and Lancia brand names. Its Luxury Brands designs, engineering��, develops, manufacturing, worldwide distribution and sale of luxury vehicles under the Ferrari and Maserati brands, management of the Ferrari racing team and supply of financial services offered in conjunction with the sale of Ferrari-branded vehicles. Its Components is engaged in production and sale of lighting components, engine control units, suspensions, shock absorbers, electronic systems, and exhaust systems and activities in powertrain (engine and transmissions) components, engine control units, plastic molding components and in the after-market carried out under the Magneti Marelli brand name; cast iron components for engines, gearboxes, transmissions and suspension systems, and aluminum cylinder heads under the Teksid brand name; and design and production of industrial automation systems ! and relat! ed products for the automotive industry under the Comau brand name.
The Company designs, engineers, manufactures, distributes and sells vehicles and service parts under 11 mass-market brands and designations. As of December 31, 2013, it has 50 parts distribution centers throughout the world to support its customer care efforts in each of its regions. The Company�� Mopar brand accessories allow its customers to customize their vehicles by including after-market sales of products from side steps and lift-kits, to graphics packages, such as racing stripes, and custom leather interiors. The Company sells mass-market vehicles in all segments of the passenger car and truck markets. Its passenger car product portfolio includes vehicles such as the iconic Fiat 500 (which has sold more than 1 million units globally since its launch in 2007), Alfa Romeo Giulietta, Dodge Charger, Chrysler 200 and Lancia Ypsilon. Its light commercial vehicles include vans such as the Fiat Professional Doblo, Fiat Professional Ducato and Ram ProMaster, and light and heavy-duty pick-up trucks such as the Ram 1500 and 2500/3500. The Company also sells SUVs and CUVs in a number of vehicle segments, such as the Jeep Grand Cherokee, including expanding into the small SUV segment market with the recently-unveiled Jeep Renegade.
The Company sells components and production systems under Magneti Marelli, Teksid and Comau brands. Magneti Marelli is engaged in designs and productions of automotive systems and components. Through Magneti Marelli, it designs and manufactures automotive lighting systems, powertrain (engines and transmissions) components and engine control unit, electronic systems, suspension systems and exhaust systems, and plastic components and modules. The Teksid brand is engaged in the production of grey and nodular iron castings. Under the Teksid brand it produces engine blocks, cylinder heads, engine components, transmission parts, gearboxes and suspensions. Through Teksid Aluminum, it is also in! volved in! the production of aluminum cylinder heads and engine components.
Comau produces advanced manufacturing systems through an international network. Comau operates primarily in the field of integrated automation technology, delivering advanced turnkey systems to its customers. Through Comau, it develops and sells a range of industrial applications, including robotics, while it provides support service, including training to customers. Comau�� principal activities include powertrain machining (from raw material to final components); mechanical assembly systems and performance testing; body welding and assembly systems, and robotics (producing versatile naked or in line robots, aimed at improving efficiency of manufacturing and quality of products manufactured). Comau�� automation technology is used in a variety of industries, including automotive, aerospace, petrochemical, military, shipbuilding and energy efficiency consultancy. Comau also provides maintenance service for the Company and other customers in Brazil.
Advisors' Opinion: - [By Alexander MacLennan]
In a move that helped push Fiat Chrysler Automobiles (NYSE: FCAU ) higher, the automaker group will spin off Ferrari sometime next year. But before that happens, Ferrari is due to pay Fiat Chrysler 2.25 billion euros, according to recent reports.
Hot Forestry Stocks To Own For 2014: Brookfield Office Properties Inc. (BPO)
Brookfield Properties Corporation is a publicly owned real estate investment firm. The firm engages in the ownership, development, and management of premier commercial properties. It also provides ancillary real estate service businesses, such as tenant service and amenities. The firm invests in the real estate markets of the United States with a focus on North American cities, including New York, Boston, Washington, D.C., Toronto, Calgary, Denver, and Minneapolis. It primarily invests in properties and development sites predominantly office buildings. The firm operates as a subsidiary of Brookfield Asset Management Inc. It was formerly known as Carena-Bancorp Holdings, Inc. and changed its name to Le Holding Carena-Bancorp Inc. in 1978. The company further changed its name to Carena-Bancorp, Inc. in 1985; to Carena Developments Limited in 1989; and to Brookfield Properties Corporation in 1996. Brookfield Properties was founded in 1923 and is based in New York, New York wi th an additional office in Toronto, Canada
Advisors' Opinion: - [By Jake L'Ecuyer]
Shares of Brookfield Office Properties (NYSE: BPO) got a boost, shooting up 13.45 percent to $19.02 after Brookfield Property Partners (NYSE: BPY) proposed to acquire Brookfield Office Properties for $19.34 per share.
- [By gurujx]
Brookfield Office Properties Inc (BPO) Reached the 52-Week High of $20.52
Brookfield Office Properties Inc. was formed under the Canada Business Corporations Act on September 5, 1978 to continue the business of Canadian Arena Corporation which was incorporated in 1923 under the Quebec Companies Act, 1920. Brookfield Office Properties Inc has a market cap of $10.41 billion; its shares were traded at around $20.52 with a P/E ratio of 19.50 and P/S ratio of 4.56. The dividend yield of Brookfield Office Properties Inc stocks is 2.73%. Brookfield Office Properties Inc had an annual average earnings growth of 16.70% over the past 10 years.
- [By Mike Arnold]
Brookfield's public assets include a 21% stake (and potentially more given certain warrants held by Brookfield) in General Growth Properties (GGP), a 51% stake in Brookfield Office Properties (BPO), a 36% stake (again, more if certain warrants are exercised) in Rouse Properties (RSE) and 21% stake in Canary Wharf Group Plc, which is majority owned by Songbird Estates Plc (SBEPF.PK).
Hot Forestry Stocks To Own For 2014: Tenaris S.A.(TS)
Tenaris S.A., through its subsidiaries, engages in the manufacture and sale of steel pipe products. The company produces and sells both seamless and welded steel tubular products and related services for the oil and gas industry, particularly oil country tubular goods used in drilling operations, and certain other industrial applications with a production process that consists in the transformation of steel into tubular products. It also offers welded steel pipe products primarily used in the construction of major pipeline projects for the transportation of gas and fluids. In addition, the company provides sucker rods, casing and tubing, drill pipes, thermal tubulars, coiled tubing, premium connections, pipe accessories, welded steel pipes for electric conduits, industrial equipment, and raw materials. Further, it involves in the ownership and licensing of steel technology, as well as in the financial sector. The company serves oil and gas companies, car manufacturers, ref ineries, and petrochemical and gas-processing plants, as well as engineering companies engaged in constructing oil and gas gathering, transportation, and processing facilities. It operates in North America, South America, Europe, the Middle East, Africa, the Far East, and Oceania. The company is headquartered in Luxembourg. Tenaris S.A. is a subsidiary of San Faustin N.V.
Advisors' Opinion: Hot Forestry Stocks To Own For 2014: Solta Medical Inc(SLTM)
Solta Medical, Inc., together with its subsidiaries, engages in the design, development, manufacture, and marketing of energy-based medical device systems for aesthetic applications primarily in North America, the Asia Pacific, Europe, and the Middle East. It offers Fraxel re:pair system for use in dermatological procedures requiring ablation, coagulation, and resurfacing of soft tissue, as well as for rhytides, pigmentation, dyschromia, fine lines, acne, surgical scars, deeper lines, wrinkles, and actinic keratoses; and Clear + Brilliant system for patients who want to take control of their aging process. The company also provides Thermage CPT system that provides non-invasive treatment options for skin tightening; Liposonix system to destroy unwanted fat cells resulting in waist circumference reduction; Isolaz system for the treatment of inflammatory acne, comedonal acne, and mild to moderate inflammatory acne; and the CLARO device, a consumer handheld device for the tre atment of mild-to-moderate inflammatory acne, including pustular acne. Its customers principally include dermatologists, plastic surgeons, general and family practitioners, gynecologists, and ophthalmologists. The company sells its products primarily through a direct sales force, as well as through independent distributors; and CLARO device through retail and associated retailer?s Websites, and television retail networks, as well as through its own website in the United States. The company was formerly known as Thermage, Inc. and changed its name to Solta Medical, Inc. in January 2009. Solta Medical, Inc. was incorporated in 1996 and is headquartered in Hayward, California.
Advisors' Opinion: - [By Tess Stynes]
Among the companies with shares expected to actively trade in Monday’s session are Sprint Corp.(S), American International Group Inc.(AIG)�and Solta Medical Inc.(SLTM)
- [By Lauren Pollock]
Solta Medical Inc.(SLTM) unveiled restructuring plans to improve its financial performance and has hired an adviser to help evaluate strategic alternatives, including a possible sale or merger of the medical aesthetics device maker. Investors cheered the news, sending shares up 7.7% to $1.97 premarket.
